[Treatment of genital herpes with alfa-2b interferon].
OBJECTIVE
To evaluate the efficacy and safety of the alfa-2b Interferon in the treatment of genital herpes.


METHODS
75 patients were treated with alfa-2b Interferon, 41 males (4 homosexuals) and 34 females, age range between 18 and 44 years. The symptom and recurrences were evaluated. The Interferon was administered at 10 million/week intradermic during 4 to 12 weeks.


RESULTS
The Interferon causes improvement in the symptoms and the recurrences were presented in 17 cases (22.6%). The mean in recurrences was 1.4 episodes per year.


CONCLUSIONS
The alpha-2b Interferon lowers the symptoms, the recurrences in time and number. Allows pregnant women that have been treated to have a normal delivery.
Granados Loarca
E A
EA
Servicio de Urología, Clínica y Hospital de Especialidades de Occidente, Quetzaltenango, Guatemala.
Estrada Barrondo
E A
EA
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins